By Jimmy Hoover ( April 16, 2015, 6:44 PM EDT) -- Federal Trade Commissioner Julie Brill said Thursday that the agency will begin "a deep dive" to analyze the motives of pharmaceutical companies suspected of pay-for-delay schemes, responding to criticism that its current analysis of anticompetitive behavior is too simple....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.